Tissue-type plasminogen activator for stroke mimics: continuing to be swift rather than delaying treatment to be sure.
about
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic strokeA qualitative description of telemedicine for acute stroke care in Norway: technology is not the issue.Tissue Plasminogen Activator Prescription and Administration Errors within a Regional Stroke System.Stroke Chameleons and Stroke Mimics in the Emergency Department.
P2860
Tissue-type plasminogen activator for stroke mimics: continuing to be swift rather than delaying treatment to be sure.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tissue-type plasminogen activa ...... delaying treatment to be sure.
@en
Tissue-type plasminogen activa ...... delaying treatment to be sure.
@nl
type
label
Tissue-type plasminogen activa ...... delaying treatment to be sure.
@en
Tissue-type plasminogen activa ...... delaying treatment to be sure.
@nl
prefLabel
Tissue-type plasminogen activa ...... delaying treatment to be sure.
@en
Tissue-type plasminogen activa ...... delaying treatment to be sure.
@nl
P2860
P1433
P1476
Tissue-type plasminogen activa ...... delaying treatment to be sure.
@en
P2093
Sean I Savitz
Waldo R Guerrero
P2860
P304
P356
10.1161/STROKEAHA.113.000927
P407
P577
2013-04-11T00:00:00Z